(Q31035650)

28 June 2017

Pre-treatment with melatonin reduces volume of cerebral infarction in a permanent middle cerebral artery occlusion stroke model in the rat. (English)

1 reference

cerebral artery occlusion

28 June 2017

0 references

1 reference

1 reference

middle cerebral artery occlusion

inferred from title

1 reference

14 December 2021

Zhong Pei

1

1 reference

28 June 2017

Hudson T S Ho

series ordinal

2

1 reference

28 June 2017

Raymond T F Cheung

series ordinal

3

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

28 June 2017

1 reference

28 June 2017

318

1 reference

28 June 2017

3

1 reference

28 June 2017

141-144

1 reference

Melatonin, mitochondria, and cellular bioenergetics

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Cardiovascular response to stress after middle cerebral artery occlusion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Melatonin decreases brain serotonin release, arterial pressure and heart rate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Reversible middle cerebral artery occlusion without craniectomy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Inhibition of excessive neuronal apoptosis by the calcium antagonist amlodipine and antioxidants in cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Anticonvulsant effects of melatonin in amygdala-kindled rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Oxidative damage in the central nervous system: protection by melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Significance of melatonin in antioxidative defense system: reactions and products

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

The ischaemic penumbra

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

Dietary vitamin E levels affect outcome of permanent focal cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2902503-4

7 January 2021

10.1016/S0304-3940(01)02503-4

Identifiers

DOI

1 reference

28 June 2017

1 reference